Creyos

Creyos Health, based in Canada, provides an innovative digital platform for cognitive and behavioral health assessments. Their solutions enhance the detection and management of cognitive health issues across various healthcare settings. Creyos Health specializes in delivering cognitive assessments through a digital platform. Founded in 2012 and headquartered in Toronto, Canada, the company has actively engaged in two funding deals.

The latest funding round, a Venture Debt of CAD 1. 5 million, occurred on July 24, 2023, with investment from FedDev Ontario. Creyos offers a digital cognitive assessment platform designed to deliver scientifically validated cognitive and behavioral health assessments. The core products include online cognitive tasks and behavioral health questionnaires that assess various domains of cognitive function, such as working memory, attention, reasoning, and executive function.

The platform aims to enhance the detection of cognitive health issues, enabling clinicians to identify conditions ranging from mild cognitive impairment (MCI) to ADHD more effectively and efficiently. These assessments are utilized by a diverse client base, including healthcare providers in various settings, such as primary care, neurology, mental health, and occupational therapy. The platform is designed for seamless integration into existing clinical workflows, ensuring accessibility for patients of all backgrounds, primarily focusing on markets in North America and Europe where there is a growing emphasis on cognitive health monitoring. Creyos generates revenue through a subscription-based model, providing access to its cognitive assessment tools and services to healthcare providers and institutions.

This transactional structure allows clients to utilize the platform's cognitive tests as part of reimbursable neuropsychological assessments or wellness visits, thus integrating seamlessly into various care models. Clients subscribe to different tiers based on their specific needs and the scale of their practice, allowing for flexible usage of the platform's features. The pricing structure is designed to accommodate both individual healthcare providers and larger healthcare institutions, facilitating access to their flagship cognitive assessment offerings. As a result, Creyos provides a comprehensive solution that enhances the ability of care teams to deliver personalized treatment options while maintaining operational efficiency.

In July 2023, Creyos raised CAD 1. 5 million in Venture Debt funding from FedDev Ontario to support the launch of a new workplace-safety platform. The company is focused on expanding its reach into additional markets in North America and Europe while enhancing its product offerings to cater to the evolving needs of healthcare providers.